Yang S, Becker F F, Chan J Y
Department of Molecular Pathology, University of Texas M.D. Anderson Cancer Center, Houston 77030.
Biochem Biophys Res Commun. 1993 Mar 31;191(3):1004-13. doi: 10.1006/bbrc.1993.1317.
An inhibitor for DNA ligase I has recently been purified from human cells. This inhibitor of 55-75 kDa forms a reversible complex with DNA ligase I, but has no effect on DNA ligase II and T4 DNA ligase, suggesting that it may play a regulatory role for DNA replication and repair. This report shows that the inhibitor was sensitive to heating at 52 degrees C and to trypsin treatment, indicating that it is a heat-labile protein. The inhibitor affected the ligation of double- and single-strand breaks in natural and synthetic DNA, but had no effect on the formation of the ligase-AMP complex and on the subsequent reaction following the formation of the AMP-DNA complex. These data indicate that the major mechanism of action for the inhibitor is the blocking of the second step of the reaction, in which the AMP moiety is transferred from the ligase-AMP to DNA. The site of interaction for the enzyme is therefore localized in a domain associated with the DNA binding or the AMP-transferring function.
最近已从人细胞中纯化出一种DNA连接酶I抑制剂。这种55 - 75 kDa的抑制剂与DNA连接酶I形成可逆复合物,但对DNA连接酶II和T4 DNA连接酶没有影响,这表明它可能在DNA复制和修复中起调节作用。本报告表明,该抑制剂对52℃加热和胰蛋白酶处理敏感,表明它是一种热不稳定蛋白。该抑制剂影响天然和合成DNA中双链和单链断裂的连接,但对连接酶 - AMP复合物的形成以及AMP - DNA复合物形成后的后续反应没有影响。这些数据表明,该抑制剂的主要作用机制是阻断反应的第二步,即AMP部分从连接酶 - AMP转移到DNA的过程。因此,该酶的相互作用位点定位于与DNA结合或AMP转移功能相关的结构域中。